Table 1.
Diagnostic and prognostic value of serum and urinary biomarkers
| Biomarker | Serum | Urinary | Diagnostic | Prognostic |
|---|---|---|---|---|
| C4 | + | + | + | |
| CB-CAP | + | + | + | |
| iC3b | + | + | + | |
| IFN-α | + | + | ||
| CXCL10 | + | + | + | + |
| Galectin-9 | + | + | ||
| SIGLEC-1 | + | + | ||
| IL-18 | + | + | ||
| ST2/IL-1R4 | + | + | ||
| BAFF | + | + | + | + |
| BCMA | + | + | ||
| APRIL | + | + | + | |
| TWEAK | + | + | + | |
| CCL2 | + | + | + | |
| CXCL16 | + | + | ||
| CD4+ cells | + | + | + | |
| CXCL4 | + | + | ||
| VCAM-1 | + | + | ||
| ALCAM | + | + | ||
| Angiostatin | + | + | ||
| NGAL | + | + | + |
The table reports the diagnostic and prognostic value of serum and urinary biomarkers presented in the paper. C4: complement 4; CB-CAP: cell-bound complement activation products; CXCL10: C-X-C motif chemokine 10; SIGLEC-1: sialic acid binding Ig-like lectin 1; ST2/IL-1R4: IL-1 receptor 4; BAFF: B cell activating factor; BCMA: B-cell maturation antigen; APRIL: a proliferation-inducing ligand; TWEAK: tumor necrosis factor-like weak inducer of apoptosis; CCL2: chemokine (C-C motif) ligand 2; VCAM-1: vascular cell adhesion molecule 1; ALCAM: activated leucocyte CAM; NGAL: neutrophil gelatinase-associated lipocalin.